Today's After-Hours MoversAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) 42.3% LOWER; announced that upon the recommendation of the ENDEAVOUR Phase 3 study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Jefferies Reiterates Hold on Yum! Brands (YUM) Following 3Q Report October 7, 2016 8:06 AM Oppenheimer Reiterates Outperform on Yum! Brands (YUM) Following 3Q Report October 6, 2016 10:13 AM Stifel Raises Price Target on Zumiez, Inc. (ZUMZ) to $18 Following Comp Sales Report October 6, 2016 10:04 AM Wedbush Raises Price Target on Zumiez, Inc. (ZUMZ) to $18; Reiterates Neutral October 6, 2016 7:58 AM BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam FailureOctober 6, 2016 6:29 AM